Ignite Creation Date:
2024-05-05 @ 5:13 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00416611
Status:
COMPLETED
Last Update Posted:
2009-01-29
First Post:
2006-12-23
Brief Title:
IMPlementation of gUideLines for the Management of Arterial hypertenSION The IMPULSION Study
Sponsor:
Hellenic Atherosclerosis Society
Organization:
Hellenic Atherosclerosis Society
Study Overview
Official Title:
IMPlementation of gUideLines for the Management of Arterial hypertenSION The IMPULSION Study
Status:
COMPLETED
Status Verified Date:
2009-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
IMPULSION
Brief Summary:
The objective of this protocol is to improve awareness treatment and control of arterial hypertension within primary prevention of target organ damage by implementing guidelines after training of the participating physicians
Detailed Description:
Physicians from 20 hospitals and 40 health centres primary health care settings were trained to implement guidelines in treating arterial hypertension
There will be a baseline recording of patients with arterial hypertension and then physicians will have to complete a one page form by ticking pre-specified boxes about the baseline status of the patients and will have to report the measures they took to improve awareness treatment and effective control of arterial hypertension After a six month effort physicians will have to complete the same form at study completion Previous training of physicians and the fact that they will have to report their success in treating hypertension will hopefully contribute to an increase in number of hypertensive patients at blood pressure target and will minimise the target organ damage The estimated reduction in coronary heart disease risk will be evaluated by a comparison of this risk as evaluated by a risk engine ie PROCAM at study completion with that of baseline
There will be a baseline recording of patients with arterial hypertension and then physicians will have to complete a one page form by ticking pre-specified boxes about the baseline status of the patients and will have to report the measures they took to improve awareness treatment and effective control of arterial hypertension After a six month effort physicians will have to complete the same form at study completion Previous training of physicians and the fact that they will have to report their success in treating hypertension will hopefully contribute to an increase in number of hypertensive patients at blood pressure target and will minimise the target organ damage The estimated reduction in coronary heart disease risk will be evaluated by a comparison of this risk as evaluated by a risk engine ie PROCAM at study completion with that of baseline
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None